BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 11994980)

  • 1. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
    Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
    Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
    Ozpolat B; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells.
    Idres N; Marill J; Chabot GG
    Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis.
    Manikam SD; Stanslas J
    J Pharm Pharmacol; 2009 Jan; 61(1):69-78. PubMed ID: 19126299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
    Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
    PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
    Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E
    Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
    Duprez E; Lillehaug JR; Gaub MP; Lanotte M
    Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
    Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K
    Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.
    Gianní M; Li Calzi M; Terao M; Guiso G; Caccia S; Barbui T; Rambaldi A; Garattini E
    Blood; 1996 Feb; 87(4):1520-31. PubMed ID: 8608243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
    Jing Y; Xia L; Lu M; Waxman S
    Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.
    Quere R; Baudet A; Cassinat B; Bertrand G; Marti J; Manchon L; Piquemal D; Chomienne C; Commes T
    Blood; 2007 May; 109(10):4450-60. PubMed ID: 17218384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
    Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT
    Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line.
    Murate T; Suzuki M; Hattori M; Takagi A; Kojima T; Tanizawa T; Asano H; Hotta T; Saito H; Yoshida S; Tamiya-Koizumi K
    J Biol Chem; 2002 Mar; 277(12):9936-43. PubMed ID: 11788605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
    Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.